Cranberry Extract Enzymatic De-esterification for Urinary Infection Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cranberry extracts for preventing urinary tract infections focus on specific components like proanthocyanidins (PACs) or phenolic acids, but their bioavailability and effectiveness are limited due to low intestinal absorption and rapid metabolism, making it unclear which components are responsible for the preventive effects.
Innovation Solution
A novel cranberry extract is developed that combines fractions enriched in proanthocyanidins, organic acids, phenolic acids, anthocyans, and sugars, with a de-esterified form achieved through enzymatic treatment with esterases, enhancing bioavailability and intestinal fermentability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If cranberry extract is focused on specific components like PACs or phenolic acids, then the extract can be standardized and manufactured consistently, but the bioavailability and effectiveness are limited due to low intestinal absorption and rapid metabolism
Solution Approach 1:
The patent uses a composite extraction approach that combines multiple cranberry components (PACs, phenolic acids, organic acids, sugars, and other phytochemicals) into a single extract formulation. This composite material strategy allows the extract to maintain manufacturing standardization while improving effectiveness through synergistic interactions among components and enhanced intestinal absorption, resolving the contradiction between standardization and bioavailability
Solution Approach 2:
The patent employs enzymatic treatment (using esterases, glucosidases, and other enzymes) to modify the chemical parameters of cranberry components, converting esterified forms into free forms that are more bioavailable. This parameter change approach maintains extract standardization while significantly improving intestinal absorption and reducing metabolism rate, thereby enhancing overall effectiveness
2Speed
If cranberry extract components are metabolized rapidly in the body, then the extract can be processed and distributed efficiently, but the ability to maintain high concentrations of active compounds in the urinary tract is reduced
Solution Approach 1:
The patent applies preliminary enzymatic treatment to convert esterified phenolic compounds into their free forms before the extract reaches the intestinal tract. This preliminary action ensures that the active compounds are in the most bioavailable form from the start, maximizing absorption into the bloodstream and subsequent concentration in the urinary tract, thereby counteracting rapid metabolism and maintaining high effective concentrations
Solution Approach 2:
The patent formulates the extract to provide continuous release and sustained presence of active compounds in the urinary tract. By combining multiple components with different metabolic profiles and using enzymatic pre-treatment to maximize bioavailability, the extract maintains continuous therapeutic concentrations in the urinary tract despite ongoing metabolism, ensuring persistent antibacterial protection
3Reliability
If the extract is de-esterified through enzymatic treatment, then the bioavailability and intestinal fermentability are enhanced, but the process complexity increases
Solution Approach 1:
The patent segments the enzymatic treatment process into distinct stages using different enzyme types (esterases for de-esterification, glucosidases for glycoside hydrolysis, and other specialized enzymes). This segmentation allows each enzyme to target specific substrates efficiently, enhancing bioavailability through systematic modification of different compound classes while keeping the overall process manageable through modular organization
Solution Approach 2:
The patent employs a multi-functional enzymatic system where a combination of different enzymes works synergistically to modify multiple types of cranberry compounds simultaneously. This universal approach enhances the bioavailability of diverse components (PACs, phenolic acids, organic acids, and sugars) through a single integrated treatment process, reducing overall process complexity compared to treating each component separately
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The extract provides a concentrated composition with synergistic antibacterial effects, increasing the ability to prevent or reduce urinary tract infections by maintaining high concentrations of active compounds in the body, including phenolic acids that can exert bactericidal effects directly in the urinary tract.
Implementation Method 1
enzymatic treatment with esterases, enhancing bioavailability and intestinal fermentability
Data Source
AI summary
The present invention relates to a concentrated extract of cranberry (Vaccinium macrocarpon), the complex composition of which makes it possible to increase the antibacterial effects thereof, which is of use for the prevention or treatment of urinary infections, and in particular for the preventive treatment of urinary infections or treatment against the recurrence thereof. The invention also relates to a process for preparing such an extract, to food, nutraceutical or pharmaceutical compositions comprising the extract and to the use thereof in the treatment or prevention of urinary infections.